Nuveen Asset Management’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-152,959
| Closed | -$260K | – | 3398 |
|
2024
Q1 | $260K | Hold |
152,959
| – | – | ﹤0.01% | 3126 |
|
2023
Q4 | $474K | Buy |
152,959
+648
| +0.4% | +$2.01K | ﹤0.01% | 3021 |
|
2023
Q3 | $935K | Sell |
152,311
-40,073
| -21% | -$246K | ﹤0.01% | 2603 |
|
2023
Q2 | $1.2M | Buy |
192,384
+104,287
| +118% | +$653K | ﹤0.01% | 2566 |
|
2023
Q1 | $420K | Sell |
88,097
-10,600
| -11% | -$50.5K | ﹤0.01% | 2844 |
|
2022
Q4 | $859K | Sell |
98,697
-17,714
| -15% | -$154K | ﹤0.01% | 2742 |
|
2022
Q3 | $1.39M | Sell |
116,411
-588
| -0.5% | -$7K | ﹤0.01% | 2582 |
|
2022
Q2 | $1.67M | Buy |
116,999
+32,515
| +38% | +$464K | ﹤0.01% | 2529 |
|
2022
Q1 | $1.52M | Sell |
84,484
-17,488
| -17% | -$315K | ﹤0.01% | 2638 |
|
2021
Q4 | $2.36M | Sell |
101,972
-5,293
| -5% | -$122K | ﹤0.01% | 2490 |
|
2021
Q3 | $3.2M | Buy |
107,265
+5,865
| +6% | +$175K | ﹤0.01% | 2446 |
|
2021
Q2 | $3.46M | Buy |
101,400
+39,542
| +64% | +$1.35M | ﹤0.01% | 2437 |
|
2021
Q1 | $2.03M | Buy |
61,858
+11,841
| +24% | +$389K | ﹤0.01% | 2611 |
|
2020
Q4 | $3.08M | Buy |
+50,017
| New | +$3.08M | ﹤0.01% | 2292 |
|